Clopidogrel (Plavix) reduces the rate of thrombosis in the rat tuck model for microvenous anastomosis

Otolaryngol Head Neck Surg. 2007 Apr;136(4):573-6. doi: 10.1016/j.otohns.2006.06.1276.

Abstract

Objective: To evaluate the effect of clopidogrel on the rate of thrombosis in a rat model for venous microvascular failure.

Study design and setting: Forty rats were treated with clopidogrel or saline control via gastric gavage in a randomized, blinded fashion. After allowing for absorption and activation, each femoral vein was isolated and a venous "tuck" procedure was performed. The bleeding time and vessel patency were subsequently evaluated.

Results: The rate of vessel thrombosis was decreased in the clopidogrel-treated group compared to controls (7.9% vs 31.4%, P < 0.025). The bleeding time was longer in the clopidogrel-treated group compared to controls (250 +/- 100 seconds vs 173 +/- 59 seconds, P < 0.015).

Conclusion: Clopidogrel decreased the rate of thrombosis in the rat model for venous microvascular failure.

Significance: The use of clopidogrel may reduce the rate of venous thrombosis after free tissue transfer and may be indicated in select patients.

MeSH terms

  • Anastomosis, Surgical / adverse effects
  • Animals
  • Clopidogrel
  • Male
  • Microsurgery
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Suture Techniques*
  • Thrombosis / etiology*
  • Thrombosis / prevention & control*
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use
  • Vascular Surgical Procedures / adverse effects*
  • Veins / surgery*

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine